SIGNIFY (Completed) Study assessInG the morbidity–mortality beNefits of the If inhibitor ivabradine in patients with coronarY artery disease Medicine ivabradine Population ASCVD Phase III Starting year 2009 Publicaties SIGNIFY Director of Study drs. P.R. Nierop (Cardioloog) Rotterdam, Franciscus Gasthuis
